We further confirmed that SLC12A5 promoted tumorigenesis in vivo with subcutaneous xenograft tumor models wherein stably overexpressing SLC12A5 in 22RV-1 cells significantly increased the growth of xenograft tumors (Fig. 2H, I). This evidence concerns the gene SLC12A5 and neoplasm.